Stay updated on Pembrolizumab in Refractory Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Refractory Meningioma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision tag on the page updated from v3.5.3 to v3.5.4, signaling a new deployment of the page. This update does not change the trial details or related information.
    Difference
    0.1%
    Check dated 2026-05-18T03:54:36.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    This update changes the ClinicalTrials.gov page’s displayed revision/version from v3.5.0 to v3.5.3, indicating an internal platform release without altering the study information presented.
    Difference
    0.1%
    Check dated 2026-04-26T15:18:40.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0; the previous v3.4.3 label was removed.
    Difference
    0.1%
    Check dated 2026-03-21T16:48:38.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T08:49:00.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    The visible change is a minor revision label updated from v3.4.1 to v3.4.2; no alterations to the study content, eligibility criteria, or essential page functionality are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T17:31:08.000Z thumbnail image
  9. Check
    118 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:35:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Refractory Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.